Cargando…

Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels

This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.

Detalles Bibliográficos
Autores principales: O’Neil, Adam, Calderbank, Steve, Brown, James, Vandigo, Joe, Yin, Perry, Bratti, Keith, Howell, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644257/
https://www.ncbi.nlm.nih.gov/pubmed/36346635
http://dx.doi.org/10.1001/jamanetworkopen.2022.40513
_version_ 1784826703559786496
author O’Neil, Adam
Calderbank, Steve
Brown, James
Vandigo, Joe
Yin, Perry
Bratti, Keith
Howell, Scott
author_facet O’Neil, Adam
Calderbank, Steve
Brown, James
Vandigo, Joe
Yin, Perry
Bratti, Keith
Howell, Scott
author_sort O’Neil, Adam
collection PubMed
description This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.
format Online
Article
Text
id pubmed-9644257
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-96442572022-11-28 Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels O’Neil, Adam Calderbank, Steve Brown, James Vandigo, Joe Yin, Perry Bratti, Keith Howell, Scott JAMA Netw Open Research Letter This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior. American Medical Association 2022-11-08 /pmc/articles/PMC9644257/ /pubmed/36346635 http://dx.doi.org/10.1001/jamanetworkopen.2022.40513 Text en Copyright 2022 O’Neil A et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
O’Neil, Adam
Calderbank, Steve
Brown, James
Vandigo, Joe
Yin, Perry
Bratti, Keith
Howell, Scott
Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
title Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
title_full Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
title_fullStr Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
title_full_unstemmed Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
title_short Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
title_sort quantification of utilization management barriers for patients initiating therapy to lower lipid levels
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644257/
https://www.ncbi.nlm.nih.gov/pubmed/36346635
http://dx.doi.org/10.1001/jamanetworkopen.2022.40513
work_keys_str_mv AT oneiladam quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels
AT calderbanksteve quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels
AT brownjames quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels
AT vandigojoe quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels
AT yinperry quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels
AT brattikeith quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels
AT howellscott quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels